Arriving in the field of excess body fat treatment, retatrutide presents a distinct strategy. Different from many current medications, retatrutide functions as a double agonist, concurrently targeting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) receptors. This dual engagement promotes multiple beneficial eff… Read More